NASDAQ:CNTX
Context Therapeutics Inc.
- Stock
Last Close
1.68
14/05 20:00
Market Cap
15.49M
Beta: -
Volume Today
99.33K
Avg: 99.97K
PE Ratio
−0.80
PFCF: −0.90
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
asset turnover | ||||||
cash per share | 0.02 - | 0.03 50.50% | 17.52 52,339.10% | 2.22 87.31% | 0.91 59.29% | |
company equity multiplier | -0.01 - | -0.03 141.92% | 1.06 3,948.25% | 1.09 2.77% | 1.35 23.88% | |
days of inventory outstanding | ||||||
days of payables outstanding | ||||||
days of sales outstanding | ||||||
dividend yield | ||||||
ebit per revenue | ||||||
ebt per ebit | 1.19 - | -2.58 317.57% | 0.99 138.46% | 0.96 2.91% | 0.96 0.91% | |
effective tax rate | -0.17 - | 0.10 157.74% | 0.29 190.56% | 0.04 87.29% | ||
enterprise value multiple | -13.70 - | -22.43 63.65% | 5.76 125.67% | 1.74 69.73% | -0.14 108.22% | |
fixed asset turnover | ||||||
free cash flow per share | -0.28 - | -0.10 63.52% | -3.19 3,051.45% | -0.88 72.37% | -1.43 62.40% | |
gross profit margin | ||||||
interest coverage | -4.89 - | -3.89 20.39% | -163.85 4,112.11% | -28.11 82.85% | ||
inventory turnover | ||||||
long term debt to capitalization | -0.00 - | |||||
net income per ebt | 1.17 - | 1 14.70% | 0.71 28.91% | 0.96 35.51% | 1 3.82% | |
net profit margin | ||||||
operating cash flow per share | -0.28 - | -0.10 63.52% | -3.11 2,964.39% | -0.85 72.67% | -1.43 68.83% | |
operating profit margin | ||||||
payables turnover | ||||||
pretax profit margin | ||||||
price fair value | -2.17 - | -3.08 41.60% | 0.16 105.07% | 0.30 91.71% | 1.52 407.69% | |
receivables turnover | ||||||
return on assets | -27.36 - | 14.22 151.96% | -0.14 101.02% | -0.38 159.80% | -1.49 296.36% | |
return on capital employed | 0.23 - | 0.28 25.55% | -0.22 176.98% | -0.44 102.94% | -2.11 377.29% | |
return on equity | 0.31 - | -0.39 225.71% | -0.15 60.79% | -0.41 167.00% | -2.02 391.00% | |
total debt to capitalization | -10.31 - | -0.54 94.74% | 0.00 - |
All numbers in USD (except ratios and percentages)